Toru Hifumi to Pyrazines
This is a "connection" page, showing publications Toru Hifumi has written about Pyrazines.
Connection Strength
0.096
-
Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients. Crit Care. 2020 08 12; 24(1):497.
Score: 0.096
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.